To study the changes in fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension
- PMID: 30825908
- DOI: 10.1016/j.preghy.2018.02.011
To study the changes in fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension
Abstract
Objective: To compare the efficacy of intravenous labetalol or oral nifedipine in treatment of acute maternal hypertension and study the fetal hemodynamic changes using color Doppler ultrasound that follows treatment.
Study design: Thirty women with severe preeclampsia having acute hypertension (more than or equal to 160/105 mmHg) were randomized in 2 groups to receive intravenous labetalol or oral nifedipine until blood pressure was lowered to less than or equal to 140/90 mmHg. Doppler vascular indices namely pulsatility index, resistance index, S/D ratio of umbilical (UA) and middle cerebral artery (MCA) were measured baseline at the time of acute severe hypertension and repeated after control of blood pressure, to assess the changes in fetal hemodynamics if any with labetalol or nifedipine.
Results: Both nifedipine and labetalol were found to be effective when used for rapid control of blood pressure. Mean age of women in both groups and mean gestational age was statistically comparable. No change in fetal heart rate before and after treatment was observed in both groups. Doppler vascular indices of UA and MCA showed no significant changes as compared to baseline values in both groups.
Conclusion: The use of labetalol and nifedipine were not related to any significant changes in fetal Doppler, which is reassuring about the safety of these drugs when treating acute severe hypertension in pregnancy. Choice between these two drugs should be based on cost, availability respective contraindications, and clinician's experience.
Keywords: Doppler; Hypertension; Labetalol; Nifedipine; Pregnancy.
Copyright © 2018. Published by Elsevier B.V.
Similar articles
-
To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.Pregnancy Hypertens. 2020 Jul;21:180-183. doi: 10.1016/j.preghy.2020.05.014. Epub 2020 May 29. Pregnancy Hypertens. 2020. PMID: 32570152 Clinical Trial.
-
Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.Am J Obstet Gynecol. 2020 Sep;223(3):441.e1-441.e8. doi: 10.1016/j.ajog.2020.06.018. Epub 2020 Jun 13. Am J Obstet Gynecol. 2020. PMID: 32544404 Clinical Trial.
-
Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.J Clin Pharm Ther. 2016 Dec;41(6):657-661. doi: 10.1111/jcpt.12439. Epub 2016 Aug 31. J Clin Pharm Ther. 2016. PMID: 27578562 Clinical Trial.
-
A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.Semin Perinatol. 2015 Nov;39(7):548-55. doi: 10.1053/j.semperi.2015.08.011. Epub 2015 Sep 4. Semin Perinatol. 2015. PMID: 26344738 Review.
-
Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis.Hypertens Pregnancy. 2023 Dec;42(1):2209637. doi: 10.1080/10641955.2023.2209637. Hypertens Pregnancy. 2023. PMID: 37434338 Review.
Cited by
-
Endovascular ultrasound renal denervation to lower blood pressure in young hypertensive women planning pregnancy: study protocol for a multicentre randomised, blinded and sham controlled proof of concept study.BMJ Open. 2023 Sep 29;13(9):e071164. doi: 10.1136/bmjopen-2022-071164. BMJ Open. 2023. PMID: 37775290 Free PMC article.
-
Antihypertensive Medications for Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis.Healthcare (Basel). 2022 Feb 9;10(2):325. doi: 10.3390/healthcare10020325. Healthcare (Basel). 2022. PMID: 35206939 Free PMC article. Review.
-
DeepStack-DTIs: Predicting Drug-Target Interactions Using LightGBM Feature Selection and Deep-Stacked Ensemble Classifier.Interdiscip Sci. 2022 Jun;14(2):311-330. doi: 10.1007/s12539-021-00488-7. Epub 2021 Nov 3. Interdiscip Sci. 2022. PMID: 34731411
-
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.Cochrane Database Syst Rev. 2018 Oct 1;10(10):CD002252. doi: 10.1002/14651858.CD002252.pub4. Cochrane Database Syst Rev. 2018. PMID: 30277556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical